Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)

Mengyu Guo; Mingjing Cao; Jiufeng Sun; Ziwei Chen; Xin Wang; Lianpan Dai; George F. Gao; Yuliang Zhao; Yaling Wang; Chunying Chen

doi:10.1038/s41392-024-01739-x

Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)

Mengyu Guo, Mingjing Cao, Jiufeng Sun, Ziwei Chen, Xin Wang, Lianpan Dai, George F. Gao, Yuliang Zhao, Yaling Wang, Chunying Chen

Houston Methodist

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Signal Transduction and Targeted Therapy, published online 16 December 2023 In this article¹ Mengyu Guo, Mingjing Cao, and Jiufeng Sun are equally contributing authors. This information is presented in the accepted version of the manuscript, but was inadvertently overlooked during the production process. The original article has been corrected.

Original language	English (US)
Article number	22
Journal	Signal Transduction and Targeted Therapy
Volume	9
Issue number	1
DOIs	https://doi.org/10.1038/s41392-024-01739-x
State	Published - Dec 2024

ASJC Scopus subject areas

Genetics
Cancer Research

Access to Document

10.1038/s41392-024-01739-x

Fingerprint

Dive into the research topics of 'Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)'. Together they form a unique fingerprint.

Cite this

Guo, M., Cao, M., Sun, J., Chen, Z., Wang, X., Dai, L., Gao, G. F., Zhao, Y., Wang, Y., & Chen, C. (2024). Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8). Signal Transduction and Targeted Therapy, 9(1), Article 22. https://doi.org/10.1038/s41392-024-01739-x

Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8). / Guo, Mengyu; Cao, Mingjing; Sun, Jiufeng et al.
In: Signal Transduction and Targeted Therapy, Vol. 9, No. 1, 22, 12.2024.

Research output: Contribution to journal › Comment/debate › peer-review

Guo, M, Cao, M, Sun, J, Chen, Z, Wang, X, Dai, L, Gao, GF, Zhao, Y, Wang, Y & Chen, C 2024, 'Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)', Signal Transduction and Targeted Therapy, vol. 9, no. 1, 22. https://doi.org/10.1038/s41392-024-01739-x

@article{44a063d9c37f40f3bc67b5cc85f85f03,

title = "Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)",

abstract = "Correction to: Signal Transduction and Targeted Therapy, published online 16 December 2023 In this article1 Mengyu Guo, Mingjing Cao, and Jiufeng Sun are equally contributing authors. This information is presented in the accepted version of the manuscript, but was inadvertently overlooked during the production process. The original article has been corrected.",

author = "Mengyu Guo and Mingjing Cao and Jiufeng Sun and Ziwei Chen and Xin Wang and Lianpan Dai and Gao, {George F.} and Yuliang Zhao and Yaling Wang and Chunying Chen",

note = "Publisher Copyright: {\textcopyright} 2024, The Author(s).",

year = "2024",

month = dec,

doi = "10.1038/s41392-024-01739-x",

language = "English (US)",

volume = "9",

journal = "Signal Transduction and Targeted Therapy",

issn = "2095-9907",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Correction

T2 - Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)

AU - Guo, Mengyu

AU - Cao, Mingjing

AU - Sun, Jiufeng

AU - Chen, Ziwei

AU - Wang, Xin

AU - Dai, Lianpan

AU - Gao, George F.

AU - Zhao, Yuliang

AU - Wang, Yaling

AU - Chen, Chunying

PY - 2024/12

Y1 - 2024/12

N2 - Correction to: Signal Transduction and Targeted Therapy, published online 16 December 2023 In this article1 Mengyu Guo, Mingjing Cao, and Jiufeng Sun are equally contributing authors. This information is presented in the accepted version of the manuscript, but was inadvertently overlooked during the production process. The original article has been corrected.

AB - Correction to: Signal Transduction and Targeted Therapy, published online 16 December 2023 In this article1 Mengyu Guo, Mingjing Cao, and Jiufeng Sun are equally contributing authors. This information is presented in the accepted version of the manuscript, but was inadvertently overlooked during the production process. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85182489589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85182489589&partnerID=8YFLogxK

U2 - 10.1038/s41392-024-01739-x

DO - 10.1038/s41392-024-01739-x

M3 - Comment/debate

C2 - 38228648

AN - SCOPUS:85182489589

SN - 2095-9907

VL - 9

JO - Signal Transduction and Targeted Therapy

JF - Signal Transduction and Targeted Therapy

IS - 1

M1 - 22

ER -

Correction: Durable and enhanced immunity against SARS-CoV-2 elicited by manganese nanoadjuvant formulated subunit vaccine (Signal Transduction and Targeted Therapy, (2023), 8, 1, (462), 10.1038/s41392-023-01718-8)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this